Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
NYS Entity Status
NYS Filing Date
NOVEMBER 13, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - A & V ALLIANCE LLC
AROUND THE WEB
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Subway Delays, Again, Disrupt Commutes; L.I.R.R. Will Offer Some Discounts
By EMMA G. FITZSIMMONS - Tuesday Jun 20, 2017
In what has become a seemingly weekly ritual, a series of problems cropped up across the city during the morning rush, including signal issues and a train with mechanical problems.
- Big Tech’s Half-Hearted Response To Fake News And Election Hacking
By Cale Guthrie Weissman - Friday Sep 15, 2017
Despite big hand waves, Facebook, Google, and Twitter aren’t doing enough to stop misinformation.
Every day a new front emerges in Big Tech’s battle against fake news. Signs of trouble reared their head during the election, when hyper-partisan misinformation began materializing on Facebook. Months later it became known that many of these sites had been weaponized in a larger misinformation campaign spearheaded by external players, including the Russian government.
- The Look: New York City Parks in the Summer: Romance, Games and a Performance for a Dying Tree
By DANIEL ARNOLD, JOANNA NIKAS and EVE LYONS - Saturday Sep 2, 2017
Daniel Arnold spent the last two months photographing parks in all five boroughs. The experience showed him “a very different pulse of the city.”
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]